Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00557180 · ClinicalTrials.gov registry record
Examining the Link Between Obesity, Inflammation, and Response to Asthma Medications
A clinical trial, sponsored by National Jewish Health.
- Completed
- Registry status
- 33
- Enrollment target
NCT00557180 is a clinical trial that has completed, run by National Jewish Health. The registered enrollment target is 33 participants.
The verdict
NCT00557180 has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- 33 participants
- Enrollment target
Study Summary
Asthma is a common, long-term disease that is caused by inflammation of the airways. Inflammation also plays a role in obesity and may affect the way a person responds to asthma medication. This study will examine the relationship between obesity and inflammation and the effect they have on response to corticosteroid asthma medications.
Interventions
- DRUG Tiotropium bromide
- DRUG Beclomethasone dipropionate HFA
- DRUG Salmeterol xinafoate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2007-10 |
| Est. Completion | 2011-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00557180
The ClinicalTrials.gov registry entry for NCT00557180 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Jewish Health, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Tiotropium bromide is the first listed.
NCT00557180 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00557180 about?
NCT00557180 is a clinical study titled "Examining the Link Between Obesity, Inflammation, and Response to Asthma Medications". Asthma is a common, long-term disease that is caused by inflammation of the airways. Inflammation also plays a role in obesity and may affect the way a person responds to asthma medication. This study will examine the relationship between obesity and inflammation and the effect they have on response...
What is the current status of trial NCT00557180?
This trial is currently completed. The enrollment target is 33 participants. The study started on 2007-10. Estimated completion is 2011-02.
What interventions are being tested in trial NCT00557180?
The interventions under investigation include: Tiotropium bromide (DRUG), Beclomethasone dipropionate HFA (DRUG), Salmeterol xinafoate (DRUG).
Who is sponsoring clinical trial NCT00557180?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.